CIK 0000730272
- Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042729386
- Phone
- +1 781-449-9560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- 4 Shares withheld for taxes Chief Operating Officer gave up 175 shares (to pay taxes)
- 4 Planned sale Director sold 26,756 shares at an average $152.51 ($4,080,663)
- 4 Open-market buy Director bought 250 shares at $150.69 ($37,673)
- 4 Grant or award CFO acquired 6,435 shares (grant or award)
- 4 Shares withheld for taxes Senior VP, R&D gave up 386 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 10,142 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 1,239 shares (to pay taxes)
- 4 Grant or award Chief Executive Officer acquired 14,480 shares (grant or award)
- 4 Shares withheld for taxes CFO gave up 316 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 343 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 1,285 shares (to pay taxes)
- 4 Shares withheld for taxes Senior VP, R&D gave up 391 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 2,825 shares (to pay taxes)
- 4 Shares withheld for taxes Senior VP, R&D gave up 275 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 543 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 2,380 shares (to pay taxes)
- 4 Option exercise Director acquired 11,808 shares (option exercise)
- 4 Open-market sale Director sold 24,246 shares at $139.67 ($3,386,439)
- 4 Shares withheld for taxes CFO gave up 367 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 861 shares (to pay taxes)
Page 4 of 34 · 669 filings